US equity futures on Tuesday showed a second-day rise as investors are keeping an eye on the latest news about the Omicron variant of the coronavirus.
what’s happening
-
Dow Jones Industrial Average 30 Futures
YM00,
+ 0.97%Increased by 297 points (0.8%) to 35509
-
S & P 500 futures
ES00,
+ 1.27%Increased by 4.1%, or 52 points, to 4642
-
Nasdaq 100 Futures
NQ00,
+ 1.75%1.7%, or 268 points up to 16111
30 Dow Jones Industrial Averages on Monday
DJIA,
+ 1.87%
The S & P 500 rose 657 points (1.9%) to 35227.
SPX,
+ 1.17%
Up 53 points (1.2%) to 4592 to return to the 50-day moving average and Nasdaq Composite Index
COMP,
+ 0.93%
Added 140 points to 15225, or 0.9%.
What is driving the market
The market continues to hold the view expressed by President Biden’s chief medical adviser, Dr. Anthony Fauci, and the early signs of the Omicron variant of coronavirus are that it is less dangerous than the Delta variant. ..
Even better news about the virus came as GlaxoSmithKline
GSK,
+ 1.24%
On Tuesday, a new preclinical study said the sotrovimab antibody retained the mutant activity.
Marshall Gittler, Head of Investment Research at BD Swiss Holding, said:
China’s decision to lower the bank’s reserve requirement ratio on Monday was also strong.
But more concerned for traders is the buildup of Russian troops along the Ukrainian border. Biden will make a video call with Russian President Vladimir Putin on Tuesday.
On the corporate side, Intel
INTC,
+ 3.53%
Shares surged in pre-market transactions with plans to list shares on Mobileye’s self-driving car unit.
Dow futures surged nearly 300 points as rebounds continued from Omicron concerns
Source link Dow futures surged nearly 300 points as rebounds continued from Omicron concerns
The post Dow futures surged nearly 300 points as rebounds continued from Omicron concerns appeared first on Eminetra.
